O2Micro Reports Fourth Quarter and Fiscal 2015 Financial Results
Jan 27, 2016 13:00 pm UTC| Business
GEORGE TOWN, Grand Cayman, Jan. 27, 2016 -- Operational and Strategic Highlights: O2Micro continues to lower operating expenses. Company lowers fiscal year 2015 operating expenses by $7.4 million on a year-over-year...
Fibrocell Highlights Recent Pipeline Accomplishments
Jan 27, 2016 13:00 pm UTC| Business
Patient Dosing in Phase II Trial of azficel-T for Chronic Dysphonia CompletedPreclinical Toxicology Study for FCX-007 InitiatedPositive POC Data Shows FCX-013 Reduces Dermal Thickness of Fibrotic Tissue EXTON, Pa., Jan. ...
Depomed Announces Save the Date for 2016 Analyst and Investor Day
Jan 27, 2016 13:00 pm UTC| Business
NEWARK, Calif., Jan. 27, 2016 -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will hold an Analyst and Investor Day in New York City on Wednesday, March 23, 2016 from 9:00 a.m. ET – 11:30 a.m. ET (6:00 a.m. PT –...
Pacific Mercantile Bank Expands Small Business Lending Programs
Jan 27, 2016 13:00 pm UTC| Business
COSTA MESA, Calif., Jan. 27, 2016 -- Pacific Mercantile Bank (“the Bank”), the wholly owned subsidiary of Pacific Mercantile Bancorp (NASDAQ:PMBC), today announced that it is now participating in the California State...
Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain
Jan 27, 2016 13:00 pm UTC| Business
MALVERN, Pa., Jan. 27, 2016 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today announced that the...
Atara Bio Announces Participation in Two Upcoming Investor Conferences
Jan 27, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 27, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with unmet medical needs in diseases that have...
Jan 27, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Jan. 27, 2016 -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases, today announced that Dimension’s Chief...
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.